Adding Cytokines to In Vitro Human Culture Media to Improve Embryogenesis and Implantation
NCT ID: NCT02420886
Last Updated: 2018-10-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
443 participants
INTERVENTIONAL
2015-05-16
2016-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving Embryogenesis by Adding Growth Factors to In Vitro Human Culture Media
NCT02426008
Novel Approach for Embryo Transfer Medium by Adding Cytokine to Hyaluronan Enriched Embryo Transfer Medium (Embryo Glue)
NCT02422134
Comparative Study of Three Different Embryo Transfer Media in ICSI Cycles
NCT02792673
Effect of Protein Concentration on Human Embryo Development
NCT03630848
Comparison of Single vs Group Embryo Culture in Micro-well Group Culture Dish
NCT02050516
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cytokines supplemented In Vitro single culture media
We will add Cytokines (LIF, HB-EGF and GM-CSF) to LIFEGLOBAL culture media and assess the embryogenesis and pregnancy.
Adding LIF, HB-EGF and GM-CSF to Lifeglobal human IVF culture media
Traditional Single step culture media
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Adding LIF, HB-EGF and GM-CSF to Lifeglobal human IVF culture media
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Banon IVF Center Assiut, Egypt
OTHER
Ibn Sina Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Muhammad Fawzy
IVF Laboratory Director
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Banon IVF Center
Asyut, , Egypt
Ibnsina IVF center
Sohag, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Fawzy M, Emad M, Elsuity MA, Mahran A, Abdelrahman MY, Fetih AN, Abdelghafar H, Sabry M, Nour M, Rasheed SM. Cytokines hold promise for human embryo culture in vitro: results of a randomized clinical trial. Fertil Steril. 2019 Nov;112(5):849-857.e1. doi: 10.1016/j.fertnstert.2019.07.012. Epub 2019 Sep 21.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Ibnsina IVF center
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.